FDA clears mixed reality surgical planning tool from apoQlar

A surgeon uses mixed reality to visualize 3D holograms. [Image courtesy of apoQlar]apoQlar announced today that it received FDA 510(k) clearance for its VSI HoloMedicine mixed reality software for surgeons.

Hamburg, Germany-based apoQlar designed VSI HoloMedicine to enable surgeons to plan complex procedures with 3D holographic technology.

According to a news release, FDA clearance makes the U.S. the 30th country to clear the apoQlar technology. The company intends to distribute in the U.S. through its Miami, Florida-based subsidiary. It expects commercial availability in the second quarter of 2023.

Following the clearance, apoQlar said it intends to raise a Series A funding round. It marks the medical metaverse company’s first-ever fundraising campaign as it looks to scale VSI HoloMedicine.

“With mixed reality, we are no longer bound to physical objects in a physical world,” said apoQlar co-founder and CEO Sirko Pelzl. “We ca…

Read more
  • 0